Analysts See $-0.03 EPS for TSO3 Inc. (TOS)

March 20, 2018 - By Louis Casey

 Analysts See $ 0.03 EPS for TSO3 Inc. (TOS)

Analysts expect TSO3 Inc. (TSE:TOS) to report $-0.03 EPS on March, 21 before the open.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $-0.03 EPS. After having $-0.03 EPS previously, TSO3 Inc.’s analysts see 0.00 % EPS growth. The stock decreased 0.82% or $0.01 during the last trading session, reaching $1.21. About 202,946 shares traded. TSO3 Inc. (TSE:TOS) has 0.00% since March 20, 2017 and is . It has underperformed by 16.70% the S&P500.

TSO3 Inc. (TSE:TOS) Ratings Coverage

Among 3 analysts covering TS03 (TSE:TOS), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. TS03 has $5.25 highest and $3.25 lowest target. $4.54’s average target is 275.21% above currents $1.21 stock price. TS03 had 8 analyst reports since July 21, 2015 according to SRatingsIntel. On Tuesday, July 21 the stock rating was initiated by M Partners with “Buy”. The stock has “Buy” rating by Canaccord Genuity on Wednesday, January 27. On Monday, June 26 the stock rating was maintained by Canaccord Genuity with “Buy”. The firm earned “Outperform” rating on Thursday, June 15 by RBC Capital Markets.

TSO3 Inc. engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices. The company has market cap of $112.35 million. The company's principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States. It currently has negative earnings. It also develops and sells the STERIZONE 125L+ sterilizer, which is designed for terminal sterilization of heat and moisture sensitive medical devices, and is intended for the reprocessing of general instruments, rigid channel instruments, and single/multi-channel rigid endoscopes, as well as short and long single/multi-channel flexible endoscopes; and STERIZONE CI+ chemical indicator in Canada.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.